<i>Limosilactobacillus reuteri</i> ZY15 Alleviates Intestinal Inflammation and Barrier Dysfunction via AKT/mTOR/HIF-1α/RORγt/IL-17 Signaling and the Gut Microbiota in ETEC K88-Challenged <i>Mice</i>.

Antioxidants (Basel) · 2025 · PMC11763039 · PMID 39857392

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

extremely significantp < 0.10so close (0.05 < p ≤ 0.1)

p < 0.05 and p < 0.01 values were considered significant and extremely significant, respectively, whereas 0.05 < p < 0.10 indicated a tendency. 3.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.